Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain

NCT00410943 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: OROS Hydromorphone HCI SR (slow release)

Sponsor

Alza Corporation, DE, USA